Pasar al contenido principal

PEPTIDOS COMO AGENTES TERAPEUTICOS: MODULACION DE INTERACCIONES PROTEINA-PROTEINA Y TRANSPORTE AL CEREBRO

BIO2013-40716-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier

  • Prades, Roger
  • Oller-Salvia, Benjamí
  • Schwarzmaier, Susanne M.
  • Selva, Javier
  • Moros, María
  • Balbi, Matilde
  • Grazú, Valeria
  • Fuente, Jesús M. de la
  • Egea, Gustavo
  • Plesnila, Nikolaus
  • Teixidó, Meritxell
  • Giralt, Ernest
The blood-brain barrier (BBB) is a formidable physical and enzymatic barrier that tightly controls the passage of molecules from the blood to the brain. In fact, less than 2 % of all potential neurotherapeutics are able to cross it. Here, by applying the retro-enantio approach to a peptide that targets the transferrin receptor, a full protease-resistant peptide with the capacity to act as a BBB shuttle was obtained and thus enabled the transport of a variety of cargos into the central nervous system., This study was supported by grants from ARAID, MINECO-FEDER (BIO2013-40716, BFU-2009-0786, and BFU-2012-33932), and the Generalitat de Catalunya (XRB and 2014-SGR-521). B.O.-S. is supported by a “La Caixa”/IRB Barcelona fellowship. We thank FARA, FEDAES/GENEFA, and the BABEL FAMILY for support., Peer reviewed, Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics

  • López, Abraham
  • Herranz-Trillo, Fátima
  • Kotev, Martin
  • Gairí, Margarida
  • Guallar, Víctor|||0000-0002-4580-1114
  • Bernadó, Pau
  • Millet, Oscar
  • Tarragó, Teresa
  • Giralt, Ernest
Deciphering conformational dynamics is crucial for understanding the biological functions of proteins and for designing compounds targeting them. In particular, providing an accurate description of microsecond–millisecond motions opens the opportunity for regulating protein–protein interactions (PPIs) by modulating the dynamics of one interacting partner. Here we analyzed the conformational dynamics of prolyl oligopeptidase (POP) and the effects of active-site-directed inhibitors on the dynamics. We used an integrated structural biology approach based on NMR spectroscopy and SAXS experiments complemented by MD simulations. We found that POP is in a slow equilibrium in solution between open and closed conformations, and that inhibitors effectively abolished this equilibrium by stabilizing the enzyme in the closed conformation., This work was supported by the Institute for Research in Biomedicine, MINECO-FEDER (Bio2013-40716-R, CTQ2013-48287 and CTQ2012-32183/BQU), and the Generalitat de Catalunya (XRB and Grup Consolidat 2014SGR521). AL has received funding from the Instituto de Salud Carlos III. PB acknowledges the Agence Nationale de la Recherche (SPINHD-ANR-CHEX-2011) and the ATIP-Avenir program for financial support. FHT’s fellowship is co-funded by the INSERM and the University of Copenhagen. Technical assistance from staff at the P12 beam line (EMBL/DESY) is acknowledged., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor

  • Bayó-Puxan, Núria
  • Rodríguez-Mias, Ricard
  • Goldflam, Michael
  • Kotev, Martin
  • Ciudad, Sonia
  • Hipolito, Christopher J.
  • Varese, Monica
  • Suga, Hiroaki
  • Campos-Olivas, Ramón
  • Barril, Xavier
  • Guallar, Víctor|||0000-0002-4580-1114
  • Teixidó, Meritxell
  • García, Jesús
  • Giralt, Ernest
The modulation of protein–protein interactions (PPIs) is emerging as a highly promising tool to fight diseases. However, whereas an increasing number of compounds are able to disrupt peptide-mediated PPIs efficiently, the inhibition of domain–domain PPIs appears to be much more challenging. Herein, we report our results related to the interaction between vascular endothelial growth factor (VEGF) and its receptor (VEGFR). The VEGF–VEGFR interaction is a typical domain–domain PPI that is highly relevant for the treatment of cancer and some retinopathies. Our final goal was to identify ligands able to bind VEGF at the region used by the growth factor to interact with its receptor. We undertook an extensive study, combining a variety of experimental approaches, including NMR-spectroscopy-based screening of small organic fragments, peptide libraries, and medicinal plant extracts. The key feature of the successful ligands that emerged from this study was their capacity to expose hydrophobic functional groups able to interact with the hydrophobic hot spots at the interacting VEGF surface patch., This work was supported by the Ministry of Economy and Competitiveness and the European Fund for Regional Development (MINECO-FEDER) (Bio2013-40716-R) and the Generalitat de Catalunya (XRB and 2014-SGR-521). We also thank the NMR facility at the Scientific and Technological Centre of the University of Barcelona (CCiT UB) for their technical support., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor

  • Bayó-Puxan, Núria
  • Rodríguez-Mias, Ricard
  • Goldflam, Michael
  • Kotev, Martin
  • Ciudad, Sonia
  • Hipolito, Christopher J.
  • Varese, Monica
  • Suga, Hiroaki
  • Campos-Olivas, Ramón
  • Barril, Xavier
  • Guallar, Víctor
  • Teixidó, Meritxell
  • García, Jesús
  • Giralt, Ernest
The modulation of protein–protein interactions (PPIs) is emerging as a highly promising tool to fight diseases. However, whereas an increasing number of compounds are able to disrupt peptide-mediated PPIs efficiently, the inhibition of domain–domain PPIs appears to be much more challenging. Herein, we report our results related to the interaction between vascular endothelial growth factor (VEGF) and its receptor (VEGFR). The VEGF–VEGFR interaction is a typical domain–domain PPI that is highly relevant for the treatment of cancer and some retinopathies. Our final goal was to identify ligands able to bind VEGF at the region used by the growth factor to interact with its receptor. We undertook an extensive study, combining a variety of experimental approaches, including NMR-spectroscopy-based screening of small organic fragments, peptide libraries, and medicinal plant extracts. The key feature of the successful ligands that emerged from this study was their capacity to expose hydrophobic functional groups able to interact with the hydrophobic hot spots at the interacting VEGF surface patch., This work was supported by the Ministry of Economy and Competitiveness and the European Fund for Regional Development (MINECO-FEDER) (Bio2013-40716-R) and the Generalitat de Catalunya (XRB and 2014-SGR-521). We also thank the NMR facility at the Scientific and Technological Centre of the University of Barcelona (CCiT UB) for their technical support., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics

  • López, Abraham
  • Herranz-Trillo, Fátima
  • Kotev, Martin
  • Gairí, Margarida
  • Guallar, Víctor
  • Bernadó, Pau
  • Millet, Oscar
  • Tarragó, Teresa
  • Giralt, Ernest
Deciphering conformational dynamics is crucial for understanding the biological functions of proteins and for designing compounds targeting them. In particular, providing an accurate description of microsecond–millisecond motions opens the opportunity for regulating protein–protein interactions (PPIs) by modulating the dynamics of one interacting partner. Here we analyzed the conformational dynamics of prolyl oligopeptidase (POP) and the effects of active-site-directed inhibitors on the dynamics. We used an integrated structural biology approach based on NMR spectroscopy and SAXS experiments complemented by MD simulations. We found that POP is in a slow equilibrium in solution between open and closed conformations, and that inhibitors effectively abolished this equilibrium by stabilizing the enzyme in the closed conformation., This work was supported by the Institute for Research in Biomedicine, MINECO-FEDER (Bio2013-40716-R, CTQ2013-48287 and CTQ2012-32183/BQU), and the Generalitat de Catalunya (XRB and Grup Consolidat 2014SGR521). AL has received funding from the Instituto de Salud Carlos III. PB acknowledges the Agence Nationale de la Recherche (SPINHD-ANR-CHEX-2011) and the ATIP-Avenir program for financial support. FHT’s fellowship is co-funded by the INSERM and the University of Copenhagen. Technical assistance from staff at the P12 beam line (EMBL/DESY) is acknowledged., Peer Reviewed, Postprint (author's final draft)